Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: Balancing muscle protection and destruction

Neuromuscular Disorders

Volumn 22, Issue 1, 2012, Pages 26-33

  De Paepe, Boel ^a   Creus, Kim K ^a   Weis, Joachim ^b   De Bleecker, Jan L ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Duchenne muscular dystrophy; Heat shock proteins; Inflammatory myopathy

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DERMATOMYOSITIS; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MUSCLE BIOPSY; MUSCLE CELL; MYOSITIS; POLYMYOSITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOSITIS; MYOSITIS, INCLUSION BODY; POLYMYOSITIS; T-LYMPHOCYTES;

EID: 84855987288     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.07.007     Document Type: Article

References (38)

1. Craig E.A., Gambill B.D., Nelson R.J. Heat-shock proteins: molecular chaperones of protein biogenesis. Mol Cell Biol 1993, 13:5637-5646.
2. Banfi G., Dolci A., Verna R., et al. Exercise raises serum heat-shock protein 70 (Hsp70) levels. Clin Chem Lab Med 2004, 42:1445-1446.
3. Cohen-Sfady M., Nussbaum G., Pevsner-Fischer M., et al. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 2005, 175:3594-3602.
4. Haug M., Dannecker L., Schepp C.P., et al. The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells. Eur J Immunol 2005, 35:3163-3172.
5. Kuppner M.C., Gastpar R., Gelwer S., et al. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol 2001, 31:1602-1609.
6. Singh-Jasuja H. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med 2000, 191:1965-1974.
7. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002, 20:395-425.
8. Asea A., Kraeft S.K., Kurt-Jones E.A., et al. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000, 6:435-442.
9. Rajaiah R., Moudgil K.D. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimm Rev 2009, 8:388-393.
10. De Franco D.B., Ramakrishnan C., Tang Y. Molecular chaperones and subcellular trafficking of steroid receptors. J Steroid Biochem Molec Biol 1998, 65:51-58.
11. Kiang J.G., Tsokos G.C. Heat shock protein 70kDa: molecular biology, biochemistry, and physiology. Pharmacol Ther 1998, 80. 183-20.
12. Tavaria M., Gabriele T., Kola I., et al. A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones 1996, 1:23-28.
13. Csermely P., Schnaider T., Soti C., et al. The 90-kDa molecular chaperone family: structure, function, and clinical applications. A comprehensive review. Pharmacol Ther 1998, 79:129-168.
14. Richter K., Buchner J. Hsp90: chaperoning signal transduction. J Cell Physiol 2001, 188:281-290.
15. Deconinck N., Dan B. Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 2007, 36:1-7.
16. McDouall R.M., Dunn M.J., Dubowitz V. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 1990, 99:199-217.
17. Askanas V., Engel W.K., Nogalska A. Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation. Brain Pathol 2009, 19:493-506.
18. Banwell B.L., Engel A.G. Alpha-B-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 2000, 54:1033-1041.
19. Hohlfeld R., Engel A.G. Expression of 65-kd heat shock proteins in the inflammatory myopathies. Ann Neurol 1992, 32:821-823.
20. Ibi T. Expression of the heat shock protein 70 in inflammatory myopathies. Rinsho Shinkeigaku 1995, 35:1163-1166.
21. Bornmann L., Polla B.S., Gericke G.S. Heat shock protein 90 and ubiquitin: developmental regulation during myogenesis. Muscle Nerve 1996, 19:574-580.
22. Bornmann L., Gericke G.S., Polla B.S., et al. Expression of heat-shock/stress proteins in Duchenne muscular dystrophy. Muscle Nerve 1995, 18:23-31.
23. De Paepe B., Creus K.K., Martin J.J., et al. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. Ann NY Acad Sci 2009, 1109:441-453.
24. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003, 362:971-982.
25. Faasen A.E. Diminished heat-shock protein synthesis following mitogen stimulation of lymphocytes from aged donors. Exp Cell Res 1989, 183:326-334.
26. Njemini R., Bautmans I., Lambert M., et al. Heat shock proteins and chemokine/cytokine secretion profile in ageing and inflammation. Mech Age Develop 2007, 128:450-454.
27. Evans C.G., Wisen S., Gestwicki J.E. Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J Biol Chem 2006, 281:33182-33191.
28. Williams J.H.H., Hunter-Lavin C. Roles of Extracellular Heat Shock Proteins: A New Sense of Danger. Heat Shock Proteins: Potent Mediators of Inflammation and Immunity 2007, 39-57. Springer. A.A.A. Asea, A. De Maio (Eds.).
29. De Paepe B., Racz G.Z., Schröder J.M., et al. Expression and distribution of the nitric oxide synthases in idiopathic inflammatory myopathies. Acta Neuropathol 2004, 108:37-42.
30. Yoshida M., Xia Y. Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J Biol Chem 2003, 278:36953-36958.
31. De Bleecker J.L., De Paepe B., Vanwalleghem I.E., et al. Differential expression of chemokines in inflammatory myopathies. Neurology 2002, 58:1779-1785.
32. Nagarsekar A., Hasday J.D., Singh I.S. CXC chemokines: a new family of heat-shock proteins?. Immunol Invest 2005, 34:381-398.
33. De Paepe B., De Keyzer K., Martin J.J., et al. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies. Acta Neuropathol 2005, 109:576-582.
34. Li Y., Zhang T., Schwartz S.J. New developments in hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. Drug Resist Updates 2009, 19:17-27.
35. Chatterjee A., Dimitropoulou C., Drakopanayiotakis F., et al. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Respir Crit Care Med 2007, 176:667-675.
36. Dello Russo C., Polak P.E., Mercado P.R., et al. The heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis. J Neurochem 2006, 99:1351-1362.
37. Malhotra V., Shanley T.P., Pittet J.F., et al. Geldanamycin inhibits NF-kappaB activation and interleukin-8 gene expression in cultured human respiratory epithelium. Am J Respir Cell Mol Biol 2001, 25:92-97.
38. Elo M.A., Kaarniranta K., Helminen H.J., et al. Hsp90 inhibitor geldanamycin increases hsp70 mRNA stabilization but fails to activate HSF1 in cells exposed to hydrostatic pressure. Biochim Biophys Acta 2005, 1743:115-119.